New Zealand has authorised two psychiatrists to prescribe pharmaceutical-grade MDMA as part of supervised treatment for adults with post-traumatic stress...
For decades, psychedelic medicine sat on the margins of psychiatry, constrained by international drug controls, political controversy and the legacy...
A new executive order could position the US territory as a research destination for emerging psychedelic therapies as clinicians, researchers...
Fiji is destroying cannabis plants by the tens of thousands while simultaneously preparing for the possibility that the same plant...
Australia's landmark clinical framework could shape how psychiatrists deliver psychedelic-assisted therapies around the world For years, psychedelic medicine has largely...
The psychedelic medicine sector has spent much of the past decade fighting for scientific credibility, regulatory acceptance, and investor confidence....
Australia's psychology profession is pushing back against new psychedelic-assisted therapy training requirements, arguing that the changes exclude the majority of...
Australia's emerging psychedelic medicine sector is warning that proposed federal tax reforms could undermine the country's ability to attract investment...
Australia's medicines regulator has signalled it will reject a proposal to allow psilocybin-assisted therapy for end-of-life distress, raising fresh questions...
In Australia, psychedelic-assisted therapy has been one of the most tightly controlled medical innovations in the world. Since 2023, MDMA...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
